Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-709-1 | CAS number: 4457-71-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In vitro bacterial test and chromosomal aberration tests showed negative results with and without metabolic activation. A test to induce gene mutations in mouse lymphoma cells in both absence and presence of metabolic activation was negative. According to Column 2 in Annex VIII (Section 8.4), an in vivo test is not necessary given the consistently negative results in multiple in vitro studies.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- The study was conducted according to an appropriate OECD test method and in compliance with GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): 3-methyl-1,5-pentanediol (MPD)
- Molecular formula (if other than submission substance): C6H14O2
- Molecular weight (if other than submission substance): 118
- Physical state: transparent liquid
- Analytical purity: 99.3 %
- Purity test date: 2005-03-14
- Lot/batch No.: 62626 (supplier Kuraray Co. Ltd, Japan)
- Expiration date of the lot/batch: 2005-09-05
- Storage condition of test material: ambient temperature, dark - Target gene:
- TK locus
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- range finding test: 0.61, 1.2, 2.4, 4.9, 7.0, 10 (mmol/L) (with and without met. act.)
main test: 0, 1.2, 2.4, 4.9, 7.0, 10 (mmol/L) (with and without met. act.) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: the test substance was diluted in DMSO; the test was carried out in culture medium (RPMI 1640; with HEPES and Glutamax-I), supplemented with heat-inactivated horse serum (10 % v/v), sodium pyruvate and penicillin/streptomycin
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- without activation: 100, 200 µmol/L
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 3-methylcholanthrene
- Remarks:
- with activation: 10 µl/L
- Details on test system and experimental conditions:
-
DURATION
- Exposure duration: 24 hours at 37°C (without activation) and 4 hours at 37°C (with activation)
- Expression time (cells in growth medium): 48 hours
- Selection time (if incubation with a selection agent): 10-14 days
SELECTION AGENT (mutation assays): trifluorothymidine (TFT)
NUMBER OF REPLICATIONS: two
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- A response was considered to be positive if the induced mutant frequency (mutant frequency of the test substance minus that of the vehicle negative control) was more than 100 mutants per 1000000 clonable cells. A response was considered to be equivocal if the induced mutant frequency was more than 50 mutants per 1000000 clonable cells. Any apparent increase in mutant frequency at concentrations of the test substance causing more than 90 % cytotoxicity was considered to be an artefact and not indicative of genotoxicity.
The test substance was considered to be mutagenic in the gene mutation test at the TK-locus if it produced neither a dose-related increase in the mutant frequency nor a reproducible positive response at any of the test points. - Statistics:
- No statistical analysis was performed
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- Interpretation of results:
negative with metabolic activation
negative without metabolic activation
In conclusion, 3-methyl-1,5-pentane-diol is not mutagenic at the TK-locus of mouse lymphoma L5178Y cells under the conditions in this study. - Executive summary:
MPD was examined for its potential to induce gene mutataions at the TK-locus of cultured mouse lymphoma L5178Y cells in both absence and presence of metabolic activation system (S9 -mix). One assay was conducted; in the assay five concentrations were tested in duplicate in both absence and presence of S9 -mix. The test substance was diluted in DMSO prior to testing.
The highest concentration tested and evaluated for mutagenicity was 10 mmol/l in both the absence and presence of S9 -mix.
MPD was not cytotoxic to L5178Y. The relative total growth at the highest concentration was not decreased compared to the negative control. No increase of mutant frequency was observed at any dose level. Methyl methansulphonate MMS and 3 -methylcholanthrene were used as positive controls, respectively. Treatment with controls yielded the expected significant increase in mutant frequency.
Under the conditions of the study the test substance MPD is not mutagenic at the TK-locus of mouse lymphoma L5178Y cells.
Reference
In both the absence and presence of S9-mix no increases of the mean mutant frequency by more than 50 mutants per 1000000 clonable cells compared to negative control were observed. As exspected, the cultures treated with the positive controls exhibited significant increases in mutation frequency relative to their solvent control cultures.
Summary of the results:
Dose (mmol/L) | absence of S9 | presence of S9 | ||
mean MF | Mean RTG | mean MF | RTG | |
10 | 117 | 179 | 117 | 85 |
7 | 154 | 135 | 83 | 80 |
4.9 | 121 | 145 | 111 | 88 |
2.4 | 103 | 139 | 145 | 90 |
1.2 | 138 | 109 | 127 | 96 |
0 | 171 | 100 | 118 | 100 |
Positive and negative controls
Methyl methanesulphonate (MMS) and 3 -methylcholanthrene (MCA) were used as positive control substances in the absence and in the presence of the S9 -mix, respectively. DMSO served as negative control. The negative controls were within acceptable ranges and treatment with the positive controls yielded the exspected significant increase in mutant frequency compared to the negative control.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Additional information from genetic toxicity in vitro:
Data are available from reliable studies for all the required in vitro endpoints. Where there was more than one reliable study for an endpoint the most recent study was selected as key study.
MPD has been tested in two reliable studies according to OECD 471 and 472 and under GLP in Salmonella typhimurium TA100, TA1535, TA98, TA1537, Escherichia coli WP2 uvrA (Hiroshi Ono 1997) and S. typhimurium TA 1535, TA 1537, TA 1538, TA 98 and TA 100 and E. coli uvrA (Jonathan Kitching 1995) respectively. The test substance did not show any mutagenic activity in any of the tester strains with or without metabolic activation.
Two reliable studies are available for in vitro cytotoxicity in mammalian cells with and without metabolic activation, human lymphocytes and Chinese hamster CHL/IU cells respectively, according to OECD 473 and GLP (Huntingdon 2001 and Hiroshi Ono 1997). MPD did not show any evidence of clastogenic activity in this two in vitro cytogenetic test systems. Furthermore data published (Kusakabe, Hirokazu; Yamakage, Kohji; and other 2002) also shows that MPD did not induce structural chromosome aberration nor induce polyploidy.
Information on mutagenicity to mammalian cells is available for 3 -methylpentane-1,5 -diol from a reliable study conducted according to OECD 467 and under GLP, using mouse lymphoma L5178Y cells (M.J.S.T. Steenwinkel 2005). The highest concentration tested and evaluated for mutagenicity was 10 mmol/l in both the absence and presence of S9 -mix. The substance was not cytotoxic to L5178Y. The relative total growth at the highest concentration was not decreased compared to the negative control. No increase of mutant frequency was observed at any dose level. The test substance was observed as not mutagenic at the TK-locus of mouse lymphoma L5178Y cells.
Justification for classification or non-classification
Based on the current data-set of 3 -methylpentane-1,5 -diol there are no indications that the substance induces mutations in bacterial or mammalian cells, nor chromosome aberrations in mammalian cells. Therefore classification for mutagenicity is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.